Malaysian clearance of fixed-dose malaria combo should aid Asian uptake
This article was originally published in Scrip
Executive Summary
The recent approval in Malaysia of a new fixed-dose combination for malaria is expected to aid the uptake of the product throughout the Southeast Asian region, where pockets of resistance to traditional artemisinin therapies are emerging.